KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Free download
The report features insights and commentary from CEOs and other senior executives, working for some of the world's largest MNCs, all with responsibility for China. They discussed the challenges of doing business in China and the opportunities for growth.
跨国公司 — 未来的“中国之路”: 毕马威研究 (PDF 2.22MB)
These files require Adobe Reader to View
Case studies
Asahi, Avery Dennison, BluebellFedEx, Genpact, Honeywell, JebsenJLL, KPMG, Maersk, OMM, TescoThe Executive Centre
Related links
RSS feeds
Business Issues in China - This overview takes a general look at the China market, and gives key insights into new developments.